Form 4 Tracker
John Oyler

Director, Chief Executive Officer · 5 filings · Latest: Jun 23, 2026

BeOne Medicines Ltd.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ONC
John OylerDirector, Chief Executive OfficerJun 23, 2026
Sale
$273.783,410$933.6K0
ONC
JOHN OYLERJun 23, 2026
Proposed Sale
$273.783,410$933.6K
ONC
John OylerDirector, Chief Executive OfficerJun 16, 2026
Sale
$265.553,693$980.7K0
ONC
JOHN OYLERJun 16, 2026
Proposed Sale
$265.553,693$980.7K
ONC
John OylerDirector, Chief Executive OfficerJun 11, 2026
Sale
$257.241,949$501.4K0
ONC
JOHN OYLERJun 11, 2026
Proposed Sale
$257.241,949$501.4K
ONC
John OylerDirector, Chief Executive OfficerJun 8, 2026
Sale
$270.564,940$1.3M0
ONC
JOHN OYLERJun 8, 2026
Proposed Sale
$270.564,940$1.3M
ONC
JOHN V OYLERDec 15, 2025
Proposed Sale
$319.06100,000$31.9M
ONC
PAN-OYLER FOUNDATIONSep 16, 2025
Proposed Sale
$332.271,204$400.1K
ONC
JOHN V OYLERSep 16, 2025
Proposed Sale
$332.2727,803$9.2M
ONC
JOHN V OYLERJul 9, 2025
Proposed Sale
$244.4727,802$6.8M
ONC
PAN-OYLER FOUNDATIONJul 8, 2025
Proposed Sale
$240.991,661$400.3K
ONC
JOHN OYLERJun 23, 2025
Proposed Sale
$261.613,174$830.4K
ONC
JOHN OYLERJun 17, 2025
Proposed Sale
$256.491,460$374.5K
ONC
JOHN OYLERJun 16, 2025
Proposed Sale
$266.053,680$979.0K
ONC
JOHN OYLERJun 6, 2025
Proposed Sale
$252.775,127$1.3M
ONC
JOHN OYLERMar 10, 2025
Proposed Sale
$242.6741,210$10.0M
ONC
JOHN OYLERMar 10, 2025
Proposed Sale
$242.6741,210$10.0M
ONC
JOHN OYLERMar 7, 2025
Proposed Sale
$249.1358,590$14.6M

Page 1 of 2

Next →